Sign In
Buy ICU
$3.28
-0.250 (-7.08%)
At Close: Jun 03, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
06:32pm, Monday, 28'th Apr 2025
NEW YORK , April 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ: ICUI). Such investors are advised to con
ICU Medical, Inc. Being Investigated on Behalf of ICU Medical, Inc. Investors. Contact Levi & Korsinsky For Details
04:30pm, Thursday, 24'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possibl
ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call
08:30am, Thursday, 24'th Apr 2025
SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of
DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps
08:00am, Monday, 07'th Apr 2025
New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif.
SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
04:05pm, Thursday, 27'th Mar 2025
DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
05:30pm, Monday, 24'th Mar 2025
DENVER, March 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference
08:30am, Monday, 24'th Mar 2025
SAN CLEMENTE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company manag
NEW YORK--(BUSINESS WIRE)---- $IINN #biotech--PESG Research releases an update following Inspira Technologies' (NASDAQ: IINN)* recent strategic developments and clinical achievements: Inspira has emer
NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award
08:45am, Tuesday, 18'th Mar 2025
Company recognized for treatment recently approved in the U.S. for pediatric acute kidney injury (AKI) due to sepsis. NEW YORK , March 18, 2025 /PRNewswire/ -- SeaStar Medical (Nasdaq: ICU) has been s
ICU Medical to Participate at the KeyBanc Healthcare Forum
08:40am, Friday, 07'th Mar 2025
SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company manag
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance
04:05pm, Thursday, 27'th Feb 2025
SAN CLEMENTE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial res
ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference
04:05pm, Thursday, 13'th Feb 2025
SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company manage
ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call
04:05pm, Thursday, 13'th Feb 2025
SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of
SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market
04:05pm, Monday, 03'rd Feb 2025
DENVER, Feb. 03, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced the closing of its previously announced registered direct offering, priced
